Australia & New Zealand's Preeminent Biologics Conference

Australia & New Zealand's Preeminent Biologics Conference brings together professionals working across biologic medicines, from research and development through manufacturing, regulation and commercialisation. Discussions may cover clinical progress, biosimilars, quality, process development, supply chains, market access and patient outcomes. The conference supports knowledge exchange between scientists, healthcare leaders, policymakers, manufacturers and service providers. It offers a valuable setting for examining regional opportunities, operational challenges and collaborative pathways in advanced therapeutics. The biologics market increasingly focuses on scalable manufacturing, lifecycle value, equitable access and evidence-led innovation.